Q1 EPS Forecast for Axsome Therapeutics Decreased by Analyst
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Research analysts at HC Wainwright cut their Q1 2025 earnings estimates for Axsome Therapeutics in a research report issued to clients and investors on Thursday, February 20th. HC Wainwright analyst R. Selvaraju now anticipates that the company will earn ($1.06) per share for the quarter, down from […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Research analysts at HC Wainwright cut their Q1 2025 earnings estimates for Axsome Therapeutics in a research report issued to clients and investors on Thursday, February 20th. HC Wainwright analyst R. Selvaraju now anticipates that the company will earn ($1.06) per share for the quarter, down from […]
-logo-1200x675.png?v=20240417094222&w=240&h=240&zc=2){kind=logo}
